Libertas Bio, Inc.
New York, NY, US· latest recorded location
Libertas Bio, Inc. is named on 1 US grants and 2 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 1
- Published applications
- 2
- Inventors
- 8
- Granted in 2026 so far
- 0
- Most recent grant
- 16 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
By publication year.
Technology areas
Share of 3 documents
Recent patents
- Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient19 Sep 2024US 2024/0307398 A1
- Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient31 Aug 2023US 2023/0270746 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.